Building Your Care Team and Preparing for Your Visit
At a Glance
Preparing for a tardive dyskinesia visit means bringing a complete medication timeline, secure videos of movements, and a symptom diary. A psychiatrist, primary care clinician, and neurologist can coordinate diagnosis, medication safety, and treatment tracking.
Managing Tardive Dyskinesia (TD) requires a specialized team that understands both the brain’s movement pathways and its emotional health. Because TD is caused by medications used for psychiatric or gastrointestinal conditions, your care involves a “bridge” between two different medical worlds: psychiatry and neurology [1].
By building a strong care team and arriving prepared for your first evaluation, you can ensure your diagnosis is accurate and your treatment plan is comprehensive.
Building Your Care Team
A successful TD care plan typically involves a coordinated team, which may include:
- The Psychiatrist or Primary Care Clinician: They manage your underlying mental health or gastrointestinal condition and the dopamine-receptor-blocking agents (DRBAs) you may still need to take. They are responsible for monitoring you for any signs of psychiatric relapse if your medication doses are changed [2][1].
- The Neurologist: While not strictly required for every patient, a referral to a neurologist—especially a Movement Disorder Specialist—is highly valuable if there is diagnostic uncertainty, if movements are disabling, or if initial treatments fail [2]. They are experts in performing the AIMS exam and distinguishing TD from look-alike conditions [3][4].
Your First Visit Checklist
Because TD is defined by your medication history, your first visit will be “data-heavy.” Arriving with the following information will help your specialist make a clear diagnosis [5].
1. The Medication Timeline
This is the most critical piece of documentation. Try to create a dated list that includes [5][6]:
- Drug Names: All antipsychotics (like haloperidol, risperidone, or aripiprazole), anti-nausea drugs (like metoclopramide), over-the-counter medicines, and the reason each drug was used.
- Dates and Doses: When you started each drug, your highest dose, and when (or if) you stopped.
- Recent Changes: Note if your movements started or got worse shortly after a dose increase, decrease, or switch [7].
- Long-Acting Injections: If you receive a “depot” or monthly injection, note the name and date of your last dose [5].
2. Video Recordings
Movements can fluctuate based on stress, fatigue, or time of day. If your movements are not happening during your office visit, the doctor may miss them [8].
- Capture the Movements: Have a friend or family member record 30-60 seconds of your movements at home when you are relaxed [5].
- Show the Whole Body: While focusing on the mouth is common, try to get a shot that includes your hands, feet, and posture while sitting or walking [8]. Protect your privacy by using a secure method to share them and ensuring you consent to the recording.
3. A Symptom Diary
Keep a brief log for a week before your visit. Note how often the movements happen and, more importantly, how they affect your life [9].
- Functional Impact: Do the movements make it hard to swallow, speak, or sleep? [10]
- Social Impact: Do you feel embarrassed or avoid going out because of the movements? [11]
Evaluating Your Specialist
Not all doctors have extensive experience with TD. To ensure you are receiving the current standard of care, you can look for these signs of expertise:
- Structured Exams: An expert will not just “look at you”; they will perform a structured AIMS exam that includes “activation maneuvers” (like asking you to tap your fingers or walk) to surface hidden movements [4][3].
- Measurement-Based Care: They should talk about your “score” and use it to track whether treatments like VMAT2 inhibitors are actually working [1][12].
- Holistic View: They should ask about your distress and daily functioning, not just the visible movements [9][13].
If a clinician suggests using an anticholinergic drug (like benztropine), they might be treating a coexisting condition like drug-induced parkinsonism. However, since it could make TD worse [1][14], you should ask what specific movement is being treated and what the risks are, rather than assuming poor care [2].
Common questions in this guide
Which doctors usually treat tardive dyskinesia?
What should I bring to my first tardive dyskinesia appointment?
How can a video help with a tardive dyskinesia evaluation?
What is the AIMS exam, and why is it used for tardive dyskinesia?
Can anticholinergic medicines make tardive dyskinesia worse?
How do doctors distinguish tardive dyskinesia from other medication-related movements?
What effects of tardive dyskinesia should I discuss with my specialist?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Do you or your staff perform a structured AIMS exam with activation maneuvers at my routine check-ups?
- 2.If I need a specialist referral, how will we coordinate my care between you and the neurologist to ensure my mental health remains stable?
- 3.Can you review this full list of my past and current medications to see what might have contributed to these movements?
- 4.If you prescribe an anticholinergic medication, can you explain what specific symptoms it is meant to treat and the risks involved?
- 5.What supportive therapies, such as speech therapy or dental evaluation, do you recommend for my specific symptoms?
- 6.What is your process for distinguishing TD from other movement disorders like drug-induced parkinsonism or akathisia?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (14)
- 1
Measurement-based Diagnosis and Treatment for Tardive Dyskinesia.
Correll CU, Citrome L
The Journal of clinical psychiatry 2021; (82(5)).
PMID: 34464521 - 2
Tardive dyskinesia: Out of the shadows.
Hauser RA, Truong D
Journal of the neurological sciences 2018; (389()):1-3 doi:10.1016/j.jns.2018.02.009.
PMID: 29449008 - 3
A Modified Delphi Consensus Study of the Screening, Diagnosis, and Treatment of Tardive Dyskinesia.
Caroff SN, Citrome L, Meyer J, et al.
The Journal of clinical psychiatry 2020; (81(2)).
PMID: 31995677 - 4
How to Assess Tardive Dyskinesia Symptom Improvement With Measurement-Based Care.
McEvoy JP
The Journal of clinical psychiatry 2020; (81(6)).
PMID: 33147658 - 5
Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.
Hauser RA, Meyer JM, Factor SA, et al.
CNS spectrums 2022; (27(2)):208-217 doi:10.1017/S109285292000200X.
PMID: 33213556 - 6
Covert Dyskinesia With Aripiprazole: Tip of the Iceberg? A Case Report and Literature Review.
Gomaa H, Mahgoub Y, Francis A
Journal of clinical psychopharmacology 2021; (41(1)):67-70 doi:10.1097/JCP.0000000000001333.
PMID: 33347026 - 7
Prolonged Tardive Dyskinesia Induced by Long-Acting Paliperidone Palmitate in Schizophrenia: A Case Report.
Chen YM, Chang S
The American journal of case reports 2026; (27()):e949867 doi:10.12659/AJCR.949867.
PMID: 41518642 - 8
Telehealth for Assessing and Managing Tardive Dyskinesia: Expert Insights from a Cross-Disciplinary Virtual Treatment Panel.
El-Mallakh RS, Belnap A, Iyer S, et al.
Telemedicine journal and e-health : the official journal of the American Telemedicine Association 2023; (29(7)):1096-1104 doi:10.1089/tmj.2022.0234.
PMID: 36520584 - 9
The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation.
Farber RH, Stull DE, Witherspoon B, et al.
Journal of patient-reported outcomes 2024; (8(1)):2 doi:10.1186/s41687-023-00679-4.
PMID: 38175450 - 10
Role of Vesicular Monoamine Transporter 2 Inhibitors in Tardive Dyskinesia Management.
Sreeram V, Shagufta S, Kagadkar F
Cureus 2019; (11(8)):e5471 doi:10.7759/cureus.5471.
PMID: 31641566 - 11
From assessment to intervention: evidence-based approaches in tardive dyskinesia.
Matthews D
CNS spectrums 2025; (30(1)):e25 doi:10.1017/S1092852925000082.
PMID: 39935362 - 12
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
Hauser RA, Factor SA, Marder SR, et al.
The American journal of psychiatry 2017; (174(5)):476-484 doi:10.1176/appi.ajp.2017.16091037.
PMID: 28320223 - 13
A validation study of the Clinician's Tardive Inventory (CTI).
Trosch RM, Shillington AC, Comella CL, et al.
Parkinsonism & related disorders 2025; (135()):107812 doi:10.1016/j.parkreldis.2025.107812.
PMID: 40187154 - 14
An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders.
Vanegas-Arroyave N, Caroff SN, Citrome L, et al.
CNS drugs 2024; (38(4)):239-254 doi:10.1007/s40263-024-01078-z.
PMID: 38502289
This page is for informational purposes only and does not constitute medical advice about tardive dyskinesia. Your psychiatrist, primary care clinician, or neurologist should guide medication and referral decisions for your situation.
Get notified when new evidence is published on Tardive Dyskinesia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.